Exelixis (EXEL) Non-cash Items (2011 - 2012)

Exelixis (EXEL) recorded quarterly Non-cash Items of $13.3 million in Q1 2012, little changed quarter-over-quarter from $13.3 million in Q4 2011.

Exelixis (EXEL) Non-cash Items (2011 - 2012) Analysis & Trends

Exelixis' Non-cash Items history runs 2 years deep, the most recent figure standing at $13.3 million for Q1 2012.

In Q1 2012, Non-cash Items changed N/A year-over-year to $13.3 million; the TTM figure through Mar 2012 stood at $13.3 million (changed N/A YoY), while the FY2011 annual figure was $13.3 million, changed N/A from the prior year.
Non-cash Items was $13.3 million for Q1 2012 at Exelixis, roughly flat from $13.3 million in the prior quarter.
In the past five years, Non-cash Items ranged from a high of $13.3 million in Q4 2011 to a low of $13.3 million in Q1 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn
9	Abivax	95.45 Bn	95.45 Bn	-
10	Exelixis	13.71 Bn	12.93 Bn	590.86 Mn

Download Data